knowledge -WSS

knowledge

author：focus 2025-10-01 23:02:31 - browse：8

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Orchard's therapy for neuron disease in children wins FDA approval

Wikipedia

WSS

Neuroscience’s long legacy of racism

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Virtual Event: March of the Biosimilars

Doctors are clamoring for more clarity on Paxlovid prescribing

Leading voice in opioid treatment defends methadone clinic system

Doctors push to include dialysis machines in emergency stockpile

leisure time

knowledge

leisure time

The high cost of giving birth even with insurance

Trump used to be more articulate. What could explain the change?

Walensky prepares to leave CDC — and Congress — behind

Virtual Event: March of the Biosimilars

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Feed a cold, starve a fever? Here’s what science says

BioMarin wins approval for gene therapy to treat hemophilia A

Nurses recount patients attacks

Medical leaders decry Supreme Court decision on affirmative action

CVS Caremark has created a new ploy: the drug ‘rebate credit’

focus

Feed a cold, starve a fever? Here’s what science says

Restaurant meals are packed with calories, and we still keep eating them

Physicians and social media: If you see something, say something?

Creating egg and sperm cells from stem cells raises ethical issues

Future doctors should be trained to promote social change

How CRISPR works, explained in two minutes

hotspot

focus

Wikipedia

explore